Skip to main content

Select Drug Profiles

Original Research

When Information Is Insufficient: Inspiring Patients for Medication Adherence and the Role of Social Support Networking

Maureen Hennessey, PhD, CPCC, John W. Heryer, MD, FACS

Stakeholder Perspective

Health Plans Must “COPE” with Chronic Diseases

by Gary M. Owens, MD

Practice Management

First Generic ARB Approval Draws a Wave of Comparative Studies

Dalia Buffery, MA, ABD

Original Research, Practice Management

Addressing Costs and Continuity of Care through Innovative Solutions for Infused Therapies: A Collaborative Experience with Infliximab

Rhett Johnson, MA, Edward N. Freeman, FACMPE, MBA

Stakeholder Perspective

New Strategies Needed to Combat Increasing Costs and Optimize Use of Infused Therapies

by Richard F Radzin, PharmD

US Provider Practices Bracing for Change: New Survey Results

Caroline Helwick

Five Steps Healthcare Leaders Can Take to Address Childhood Obesity

Jennifer Lovejoy, PhD

Conference Highlights AMCP

Cost May Not Drive Formulary Choice After All

Conference Highlights AMCP

Method Used to Measure MPR Influences Adherence Rate

Conference Highlights AMCP

Pharmacists’ Monitoring of ESAs Leads to Cost¬Savings

Conference Highlights AMCP

Adding a Pharmacist to a Medical Home May Cut Costs

Conference Highlights AMCP

Step-Therapy Program to Lower Rx Costs, Keep Members Happy

Page 223 of 244
Results 2221 - 2230 of 2438